NCT04078841已完成1 期
Using ReaLife+ to Treat Post-Lyme Disease Syndrome
Optimal Health Research2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年7月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Blood test
研究概览
简要总结
To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).
详细描述
To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS). After failure of antibiotic therapy to relive persistent symptoms of Lyme Disease, the use of Acetogenins to elevate Post-Lyme Disease Syndrome.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A positive Western Blot for Lyme Disease that has been treated with antibiotics but the symptoms persist post treatment.
- •Must be able to swallow and mixed powder drink.
排除标准
- •Non Positive Western Blot test.
- •Positive Western Blot test where the indivual has not been treated with antibiotics.
结局指标
主要结局
Blood test
时间窗: 3 months
Western Blot showing "negative"
PROMIS Fatigue Scale
时间窗: 3 months
Self reported fatigue level changes as measured by the Patient-Reported Outcomes Measurement Information System, Fatigue Scale.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Study of Platelet Function After Administration of Aspirin Versus Lysine AcetylsalicylateAdverse Effect of Antithrombotic DrugsNCT02243137David Vivas30
撤回
2 期
Alipogene Tiparvovec for the Treatment of LPLD PatientsLPL DeficiencyNCT02904772UniQure Biopharma B.V.
招募中
2 期
Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLLSmall Lymphocytic LymphomaChronic Lymphocytic LeukemiaNCT04560322Massachusetts General Hospital40
终止
3 期
Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung CancerNon Small Cell Lung CancerNCT01379976Mario Negri Institute for Pharmacological Research107
已完成
不适用
Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne Vulgaris: a Prospective StudyAcne VulgarisNCT04709289Shanghai Dermatology Hospital40